# Study to Evaluate Initiation of Stalevo in Early Wearing-off

> **NCT00462007** · PHASE4 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 115 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Stalevo

## Key facts

- **NCT ID:** NCT00462007
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-08
- **Final completion:** 2007-12
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2015-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00462007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00462007, "Study to Evaluate Initiation of Stalevo in Early Wearing-off". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00462007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*